On 1 April 2013, the premiers of Canada’s provincial and territorial governments, under the auspices of the Council of the Federation, achieved a breakthrough agreement to lower the price to be paid for 6 costly generic medicines (amlodipine, atorvastatin, omeprazole, rabeprazole, ramipril,...